Navigation Links
Roche Scientist Recognized for Excellence in Peptide Chemistry
Date:10/7/2009

BOULDER, Colo., Oct. 7 /PRNewswire/ -- Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/). Hosted by Roche Colorado, the company's peptide manufacturing facility in Boulder, RCCPS is the only global conference exclusively dedicated to peptides. For Danho, who has a world-wide reputation as a leader and innovator in the field of peptide chemistry and the application of peptide chemistry to drug discovery, this was the second prestigious award he garnered this year.

"Each year, the world's leading peptide scientists honor one of their own at RCCPS for a lifetime of outstanding achievement," said the symposium's co-chair, Ralph Di Libero. "The selection of Waleed as the 2009 Meienhofer Award recipient is particularly compelling as it speaks volumes to the central role that Roche is playing, through all stages of drug development, at demonstrating the viability of synthetic peptide therapeutics."

This theme was echoed by Danho. "There were many who doubted the viability of synthetic peptides, relegating promising medicinal compounds to the shelf. Roche kept its faith in my vision for the future of peptides and their faith is beginning to bear fruit, with many synthetic peptides now providing meaningful health benefits and many more in the pipeline."

"Of course," concluded Danho, "I accept this tribute with due respect for my colleagues in the peptide field who helped advance the science to its present place of influence in the pharmaceutical industry. That is what makes the Meienhofer Award, receiving it as I did during this premier gathering of peptide scientists, such a meaningful tribute."


'/>"/>
SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
3. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
4. Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
11. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... Md., Dec. 21, 2011 The U.S. Food and Drug ... Flex Massager, imported by King International and sold by ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) The Shoulder Flex Massager is ... over the Internet. It is intended to provide users with ...
... NEW YORK, Dec. 21, 2011   Delcath Systems, Inc. ... to the Company,s Medical Advisory Board. ... the International Liver Cancer Association (ILCA), Dr. Gores will ... drug induced liver pathology to our Medical Advisory Board," ...
Cached Medicine Technology:FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 2Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 4
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Western University ... its status of “Full Accreditation” for the next seven ... on Education (COE). , “This is a magnificent achievement, ... hard work and student outcomes,” said College of Veterinary ... express my appreciation to the faculty, staff, preceptors, and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
(Date:5/24/2013)... E-Dentists.com has announced the launch of ... Media Surge, a leading medical Internet marketing agency. ... service will focus on providing dentists the help they ... their competitive keywords. The dental SEO analysis covers a ... on what their competitors are doing right. The goal ...
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
... into the gut, according to a study published this ... There are several drugs that would have more ... absorption by the lower intestine. However, in order to ... medication delivered by mouth must surmount several barriers including ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, ... and older white Americans are sicker than their counterparts in ... long as the Brits, thanks to doctors and drugs. ... care from the health-care system," explained study co-author James P. ...
... biceps (LHB) tendinopathy, which is a pain and/or tearing ... and/or a rotator cuff tear. LHB tendinopahy can be ... Because of the variety of the causes and the ... examination, including radiographic imaging to determine the diagnosis and ...
... a safe, effective way of removing bowel tumours and ... colorectal cancer, according to researchers from the University of ... time in hospital and recover more quickly from the ... way of doing surgery does not make patients with ...
... that multiple antiepileptic drugs (AEDs) used by pregnant women ... their teenagers. The research team from Karolinska University Hospital ... exposure to AEDs in utero may have a negative ... Epilepsia , a journal published by Wiley-Blackwell on ...
... , WEDNESDAY, Nov. 3 (HealthDay News) -- Higher levels ... care for Medicare patients, a new study has found. ... and Information Set revealed wide variation across the United ... of inappropriate prescriptions for the elderly, said the researchers ...
Cached Medicine News:Health News:Colonic navigation 2Health News:Older Americans Sicker Than British Peers... 2Health News:5-year results show keyhole bowel cancer surgery is safe and effective 2Health News:Teens of epileptic moms display poor school performance 2Health News:Pricey Drugs May Not Mean Better Care 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: